tiprankstipranks
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
Holding OBIO?
Track your performance easily

Orchestra BioMed Holdings (OBIO) Financial Statements

56 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently ―. The company's EPS TTM is $-1.591; its P/E ratio is -3.42; Orchestra BioMed Holdings is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 987.00K$ 778.00K$ 620.00K$ 262.00K$ 419.00K
Gross Profit$ 919.00K$ 734.00K$ 586.00K$ 215.00K$ 378.00K
EBIT$ -15.43M$ -16.88M$ -14.42M$ -12.48M$ -14.52M
EBITDA$ -15.07M$ -16.05M$ -14.35M$ -12.41M$ -14.45M
Net Income Common Stockholders$ -15.43M$ -15.98M$ -13.46M$ -12.82M$ -13.32M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 66.93M$ 65.18M$ 75.04M$ 87.59M$ 108.85M
Total Assets$ 75.32M$ 72.38M$ 82.63M$ 95.21M$ 116.36M
Total Debt$ 1.84M$ 1.45M$ 1.62M$ 1.69M$ 11.46M
Net Debt$ -65.09M$ -63.73M$ -73.41M$ -85.91M$ -97.39M
Total Liabilities$ 29.10M$ 28.26M$ 25.44M$ 27.17M$ 36.70M
Stockholders Equity$ 46.24M$ 44.13M$ 57.19M$ 68.04M$ 79.66M
Cash Flow-
Free Cash Flow$ -13.77M$ -10.31M$ -13.12M$ -10.97M$ -10.30M
Operating Cash Flow$ -13.70M$ -10.21M$ -13.11M$ -10.97M$ -10.28M
Investing Cash Flow$ 557.00K$ 10.42M$ 5.86M$ 33.15M$ 12.95M
Financing Cash Flow$ 15.04M$ 171.00K$ 18.00K$ -10.70M$ 4.00K
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Orchestra BioMed Holdings Debt to Assets

Orchestra BioMed Holdings Cash Flow

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis